repaglinide
repaglinide is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.
Drug details
- Generic Name
- repaglinide
- Sponsor
- Jubilant Biosys Limited
- NDC Codes
- 1
- Dosage Forms
- POWDER
- Active Ingredients
- REPAGLINIDE
Indications and Usage
1 INDICATIONS AND USAGE Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Repaglinide tablets are a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1) Limitation of Use : Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis (1)